Results 321 to 330 of about 210,456 (335)

Role of integrin α4 in the inhibition of fibrosis in activated hepatic stellate cells by <i>Periplaneta americana</i> extract. [PDF]

Front Pharmacol
Fang Y, Liu Y, Li D, Miu Y, Chen K, Zhou J, Xie L, Chen X, Wu J, Zhu Y, Lv L, Li W.   +11 more
europepmc   +1 more source

Proteomic analysis of liver fibrosis reveals EFEMP1 as a new modulator of focal adhesion and migration of hepatic stellate cells. [PDF]

FASEB J
Thomas C, Bouezzedine F, Bonnier D, Legagneux V, Théret N.   +4 more
europepmc   +1 more source

FGF19-Activated Hepatic Stellate Cells Release ANGPTL4 that Promotes Colorectal Cancer Liver Metastasis. [PDF]

Adv Sci (Weinh)
Fan X, Li B, Zhang F, Liu M, Kwan HY, Liu Z, Su T.   +6 more
europepmc   +1 more source

Notoginsenoside R2 attenuates hepatic fibrosis via STAT3-dependent hepatic stellate cells senescence induction and inflammatory microenvironment suppression. [PDF]

J Ginseng Res
Deng K, Li M, Li Y, Xiang L, Wang Y, Shi H, Cheng J, Huang S, Lv Z.   +8 more
europepmc   +1 more source

Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. [PDF]

Mol Metab
Muturi HT, Ghadieh HE, Asalla S, Lester SG, Belew GD, Zaidi S, Abdolahipour R, Shrestha AP, Portuphy AO, Stankus HL, Helal RA, Verhulst S, Duarte S, Zarrinpar A, van Grunsven LA, Friedman SL, Schwabe RF, Hinds TD, Kumarasamy S, Najjar SM.   +19 more
europepmc   +1 more source

Chondroitin Sulfate-Based Imatinib Nanoparticles Targeting Activated Hepatic Stellate Cells Against Hepatic Fibrosis. [PDF]

Pharmaceutics
Liu X, Fang C, Yu H, Huang L, Feng J, Luo S, Song L, Wu M, Tan Y, Dong J, Gong T, Xiao P.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis

Science Translational Medicine, 2023
Advanced hepatic fibrosis, driven by the activation of hepatic stellate cells (HSCs), affects millions worldwide and is the strongest predictor of mortality in nonalcoholic steatohepatitis (NASH); however, there are no approved antifibrotic therapies. To
Shuang Wang, Kenneth Li, Eliana Pickholz, R. Dobie, Kylie P. Matchett, N. Henderson, C. Carrico, Ian Driver, M. Borch Jensen, Li Chen, M. Petitjean, D. Bhattacharya, M. Fiel, Xiao Liu, T. Kisseleva, Uri Alon, Miri Adler, R. Medzhitov, S. Friedman   +18 more
semanticscholar   +1 more source

Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis

Journal of Cellular Physiology, 2021
Over the last two decades, our understanding of the pathological role of hepatic stellate cells (HSCs) in fibrotic liver disease has increased dramatically.
D. Ezhilarasan
semanticscholar   +1 more source